Skip to content

SION SION Available-for-Sale Debt Securities

Available-for-Sale Debt Securities at other companies

Arteris, Inc. logo
Arteris, Inc.AIP
$26.43M+1.9%
Supernus Pharmaceuticals logo
Supernus PharmaceuticalsSUPN
$199.37M-42.7%
BigBear.ai logo
BigBear.aiBBAI
$248.68M
Agilon Health logo
Agilon HealthAGL
$91.42M-60.3%
Zymeworks logo
ZymeworksZYME
$120.45M-36.3%
Sonos, Inc. logo
Sonos, Inc.SONO
$48.9M-2.9%

Other financials

Income statement

See full
Operating income-$29.6M-50.6%
Net income-$26.8M-62.5%
EPS (diluted)-$0.60+3.2%

Balance sheet

See full
Cash & equivalents$64.3M-23.2%
Total debt$8.4M-11.8%
Total equity$288.2M-18.1%
Total assets$305.0M-17.5%

Cash flow

See full
Operating cash flow-$21.8M-34.1%
CapEx--100%
Free cash flow-$21.8M-33.4%

Valuation

See full
Market cap$1.8B
Enterprise value$1.74B

Returns & leverage

See full
Return on equity-26.7%
Debt / equity0.0×
Current ratio22.6×-6.1×

Where this comes from

Reported directly by SION in its filing.

Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent.

The official record: SION’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SION's available-for-sale debt securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SION's available-for-sale debt securities?
SION (SION) reported available-for-sale debt securities of $152.83M in Q1 2026.
How has SION's available-for-sale debt securities changed year-over-year?
SION's available-for-sale debt securities decreased by 18.3% year-over-year, from $186.97M to $152.83M.
What does available-for-sale debt securities mean?
This metric represents the fair market value of debt instruments held by the company that are neither classified as held-to-maturity nor as trading securities. It reflects the portion of the company's liquid assets invested in interest-bearing securities that can be sold to meet operational or strategic funding requirements. Changes in the valuation of these securities are typically recorded in other comprehensive income, providing insight into the company's treasury management and liquidity buffer.